List of Respiratory Clinical Trials:

  • A Randomized, Double-Blind, Multicenter Study to evaluate the Efficacy and Safety of Intravenous to Oral Solithromycin (CEM-101) compared to Intravenous to Oral Moxifloxacin in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia

Sponsor: Cempra Pharmaceuticals Inc,, USA

Protocol Number: CEO1-301


  • A Phase I/IIa Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With Respiratory Tract Infection, Consisting of an Open-label Lead-in Part Followed by a Double-blind, Placebo-controlled Part, to Evaluate the Safety, Tolerability and Clinical Activity of ALX-0171, Administered via Inhalation, in Addition to Standard of Care

Sponsor: Ablynx, Belgium

Protocol Number: ALX0171-C104